期刊文献+

兔抗凋亡蛋白酶活化因子-1多克隆抗体的制备、纯化与鉴定 被引量:1

原文传递
导出
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第1期68-69,共2页 Chinese Journal of Cellular and Molecular Immunology
基金 河南省科技厅科技攻关项目(524410050)
  • 相关文献

参考文献2

二级参考文献8

  • 1丁丽华,方言,严景华,袁斌,韩聚强,吕秋军,叶棋浓.FHL家族的克隆及其融合蛋白的纯化[J].生物技术通讯,2006,17(2):174-176. 被引量:2
  • 2丁丽华,袁斌,严景华,韩聚强,姜艳超,李杰之,叶棋浓.FHL1抗体的制备与特异性鉴定[J].细胞与分子免疫学杂志,2006,22(6):804-806. 被引量:4
  • 3Makoto Mitsunaga,Akihito Tsubota,Kohichi Nariai,Yoshihisa Namiki,Makoto Sumi,Tetsuya Yoshikawa,Kiyotaka Fujise.Early apoptosis and cell death induced by ATX-S10Na(Ⅱ)-mediated photodynamic therapy are Bax- and p53-dependent in human colon cancer cells[J].World Journal of Gastroenterology,2007,13(5):692-698. 被引量:3
  • 4Sanchez-Garcia I,Rabbitts TH.The LIM domain:a new structural motif found in zinc-finger-like proteins[J].Trends Genet,1994,10:315.
  • 5Brown S,Biben C,Ooms LM,et al.The cardiac expression of striated muscle LIM protein 1 (SLIM1) is restricted to the outflow tract of the developing heart[J].J Mol Cell Cardiol,1999,31(4):837-843.
  • 6Fimia GM,De Cesare D,Sassone-Corsi P.A family of LIM-only transcriptional coactivators:tissue-specific expression and selective activation of CREB and CREM[J].Mol Cell Biol,2000,20(22):8613-8622.
  • 7Curtiss J,Heilig JS.DeLIMiting development[J].Bioessays,1998,20(1):58-69.
  • 8Borczvk AC,Shah L,Pearson GDN,et al.Molecalar signatives in biopsy specimens of lung cancer[J].Am J Respir Crit Care Med,2004,170(2):167-174.

共引文献14

同被引文献10

  • 1Boyd MR, Gustafson KR, McMahon JB, et al. Discovery of cyanovi- fin-N, a novel human immunodeficiency virusinactivating protein that binds viral surface envelope glycoprotein gpl20: potential applications to microbicide development [ J ]. Antimierob Agents Chemother, 1997, 41 : 1521 - 1530.
  • 2Helle F, Wyehowski C, Vu-Dae N, et al. Cyanovirin-N inhibits hep- atitis C virus entry by binding to envelope protein glycans[J]. J Biol Chem, 2006, 281 (35) : 25177 - 25183.
  • 3Smee DF, Wandersee MK, CheckeRs MB, et al. Influenza A ( H1N1 ) virus resistance to eyanovirin-N arises naturally during adap- tation to mice and by passage in cell culture in the presence of the in- hibitor[J]. Antivir Chem Chemother, 2007, 18(6) : 317 -327.
  • 4Barrientos LG, Gronenborn AM. The highly specific carbohydrate-bind- ing protein cyanovirin-N: structure, anti-HIV/Ebola activity and possi- bihties for therapy[J]. Mini Rev Med Chem, 2005, 5( 1 ) : 21 -31.
  • 5Sexton A, Drake PM, Mahmood N, et al. Transgenic plant production of cyanovirin-N, an HIV microbicide[J]. FASEB J, 2006, 20:356 - 358.
  • 6Gao X, Chen W, Guo C, et al. Soluble cytoplasmic expression, rapid purification, and characterization of cyanovirin-N as a His-SUMO fu- sion[J]. Appl Microbiol Biotechnol, 2009, 85(4) : 1051 -1060.
  • 7Xiong S, Fan J, Kitazato K. The antiviral protein eyanovirin-N: the current state of its produetian and applications [ J ]. Appl Mierobiol Biotechnol, 2010, 86 (3) : 805 - 812.
  • 8Gustafson KR, Sowder RC, Henderson LE, et al. Isolation, primary sequence determination, and disulfide bond structure of cyanovirin- N, an anti-HIV ( human immunodeficiency virus) protein from the cyanobacterium nostocellipsosporum [ J ]. Biochem Biophys Res Commun, 1997, 238(1): 223 -228.
  • 9Smee DF, Baileky KW, Wong MH, et al. Treatment of influenza A ( H1 N1 ) virus infections in mice and ferrets with cyanovirin-N [ J ]. Antiviral Research, 2008, 80(3) : 266 -271.
  • 10陈伟,韩波,钱垂文,刘秋英,熊盛.蓝藻抗病毒蛋白-N基因的克隆、表达、纯化及活性鉴定[J].生物工程学报,2010,26(4):538-544. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部